THE EFFECT OF REDUCED-DOSE ORAL GLUCOCORTICOIDS DURING INDUCTION OF REMISSION INDUCTION IN SEVERE ANCA-ASSOCIATED VASCULITIS

被引：0
|
作者：
Walsh, Michael [1 ]
Merkel, Peter [2 ]
Jayne, David [3 ]
机构：
[1] McMaster Univ, St Josephs Healthcare, Hamilton, ON, Canada
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Univ Cambridge, Addenbrookes Hosp, Cambridge, England
来源：
RHEUMATOLOGY | 2019年 / 58卷
基金：
美国国家卫生研究院; 英国医学研究理事会; 芬兰科学院; 加拿大健康研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
361
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The Effects of Plasma Exchange and Reduced-Dose Glucocorticoids during Remission-Induction for Treatment of Severe ANCA-Associated Vasculitis
    Walsh, Michael
    Merkel, Peter A.
    Jayne, David
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [2] Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis
    Jayne, David R. W.
    Merkel, Peter A.
    Bekker, Pirow
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (15): : 1535 - 1535
  • [3] Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis Reply
    Furuta, Shunsuke
    Ikeda, Kei
    Nakajima, Hiroshi
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (15): : 1536 - 1537
  • [4] Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis A Randomized Clinical Trial
    Furuta, Shunsuke
    Nakagomi, Daiki
    Kobayashi, Yoshihisa
    Hiraguri, Masaki
    Sugiyama, Takao
    Amano, Koichi
    Umibe, Takeshi
    Kono, Hajime
    Kurasawa, Kazuhiro
    Kita, Yasuhiko
    Matsumura, Ryutaro
    Kaneko, Yuko
    Ninagawa, Keita
    Hiromura, Keiju
    Kagami, Shin-ichiro
    Inaba, Yosuke
    Hanaoka, Hideki
    Ikeda, Kei
    Nakajima, Hiroshi
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (21): : 2178 - 2187
  • [5] Remission induction in ANCA-associated vasculitis
    Hellmich, B.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (02): : 194 - 195
  • [6] Reduced-dose vs high-dose glucocorticoids added to rituximab and remission induction in ANCA-associated vasculitis (vol 326, pg 1536, 2021)
    Jayne, D. R. W.
    Merkel, P. A.
    Bekker, P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (17): : 1697 - 1697
  • [7] Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study
    Furuta, Shunsuke
    Nakagomi, Daiki
    Kobayashi, Yoshihisa
    Hiraguri, Masaki
    Sugiyama, Takao
    Amano, Koichi
    Umibe, Takeshi
    Kono, Hajime
    Kurasawa, Kazuhiro
    Kita, Yasuhiko
    Matsumura, Ryutaro
    Kaneko, Yuko
    Ninagawa, Keita
    Hiromura, Keiju
    Kagami, Shin-ichiro
    Inaba, Yosuke
    Hanaoka, Hideki
    Ikeda, Kei
    Nakajima, Hiroshi
    LoVAS collaborators
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (01) : 96 - 102
  • [8] Advances in remission induction therapy for ANCA-associated vasculitis
    Morris, Adam
    Geetha, Duvuru
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2023, 37 (01):
  • [9] PLASMAPHERESIS, RITUXIMAB AND LOW-DOSE CYCLOPHOSPHAMIDE FOR REMISSION INDUCTION THERAPY IN SEVERE ANCA-ASSOCIATED VASCULITIS
    Gulati, Kavita
    McAdoo, Stephen
    Galliford, Jack
    Griffith, Megan
    Levy, Jeremy
    Cairns, Tom
    Pusey, Charles
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [10] PLASMAPHERESIS, RITUXIMAB AND LOW-DOSE CYCLOPHOSPHAMIDE FOR REMISSION INDUCTION THERAPY IN SEVERE ANCA-ASSOCIATED VASCULITIS
    Gulati, Kavita
    Mcadoo, Stephen
    Tanna, Anisha
    Levy, Jeremy
    Griffith, Megan
    Cairns, Thomas
    Pusey, Charles
    RHEUMATOLOGY, 2019, 58
12345